Apellis (APLS) reports strong preliminary net product revenues in the United States for the fourth quarter of 2023, driven by robust Syfovre sales. The stock gains 15%.View live Apellis Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, APLS financials and market news.Apellis's Stock Under Pressure On Syfovre Safety Concerns: Analyst Slashes Price Target. Benzinga. ... Wedbush analyst has lowered the price target from $86 to $40, with a Neutral rating.2,045.80 +15.10(+0.74%) Apellis Pharmaceuticals, Inc. (APLS) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 68.47 +0.88 (+1.30%) At close: 04:00PM EST 68.50 +0.03... Apellis Pharmaceuticals, Inc. Common Stock (APLS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.The public offering consisted of 4,007,936 shares of common stock at the public offering price of $63.00 per share, including 833,333 shares of common stock pursuant to the full exercise of the ...These 21 analysts have an average price target of $65.0 versus the current price of Apellis Pharmaceuticals at $51.075, implying upside. Below is a summary of how these 21 analysts rated Apellis ...The drug continues to be one of the growth drivers for Apellis, with reported revenues of almost $66.6 million in the first nine months of 2023. Shares of Apellis have rallied 19.1% year to date ...Nov 13, 2017 ... ... shares of common stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any. The shares ...BofA Securities analyst Tazeen Ahmad upgraded Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) to Buy from Neutral, raising the price target to $85 from $52.. Ahmad forecasts a lower risk story from ...Apellis Pharmaceuticals Inc.’s stock APLS, +1.78% tumbled 14% early Thursday, after the company said it’s been informed of a negative trend vote on the European marketing authorization ...November 2, 2023 · 6 min read. Apellis Pharmaceuticals, Inc. APLS reported third-quarter 2023 loss of $1.17 per share, which was wider than the Zacks Consensus Estimate of a loss of 84 cents. The ...In addition, Apellis has granted the underwriters a 30-day option to purchase up to 1,312,500 additional shares of its common stock at the public offering price, less the underwriting discounts ...Apellis Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time APLS stock price.Apellis Pharmaceuticals ( NASDAQ: APLS) lost ~2% in the pre-market Friday after announcing that updated labeling information for its FDA-approved eye disease therapy Syfovre reflects risks related ...As of Q1 2023, Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) was the most commonly held stock out of the 12 stocks with biggest upside potential according to analysts.Real-time Price Updates for Apellis Pharmaceuticals Inc (APLS-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreThe firm's 50 day moving average price is $64.53 and its 200 day moving average price is $52.06. The company has a debt-to-equity ratio of 0.40, a quick ratio of …APLS | Complete Apellis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. No wonder, then, that Apellis' share price rapidly rose from ~$53 per share, to ~$93 on news of the approval, giving the company a near double-digit billion valuation. ... Apellis stock responded ...Jan 11, 2024 · Get Apellis Pharmaceuticals Inc (APLS.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Apellis Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) WALTHAM, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to 4 new employees with a grant date of February 1, 2024, as equity inducement awards outside of the company's 2017 Stock Incentive Plan (but ... On January 17, 2024, Jeffrey Eisele, Chief Development Officer of Apellis Pharmaceuticals Inc (NASDAQ:APLS), sold 5,207 shares of the company's stock, according to a recent SEC Filing. Get the ...4 days ago · The Apellis Pharmaceuticals Inc. stock price gained 0.646% on the last trading day (Friday, 9th Feb 2024), rising from $68.12 to $68.56. During the last trading day the stock fluctuated 1.89% from a day low at $68.11 to a day high of $69.40. The price has risen in 6 of the last 10 days and is up by 7.06% over the past 2 weeks. Needham Adjusts Price Target on Apellis Pharmaceuticals to $75 From $70, Maintains Buy Rating Jan. 24: MT Apellis Pharmaceuticals Insider Sold Shares Worth $872,961, According to a Recent SEC Filing ... Stock Apellis Pharmaceuticals, Inc. - …Get the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.View live Apellis Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, APLS financials and market news. The average stock forecast for Apellis Pharmaceuticals Inc (APLS) is 76.88 USD. This price target corresponds to an upside of 11.78%. The range of stock forecasts for Apellis is 49.49 - 111.30 USD. Based on the ratings of 23, the consensus recommendation for Apellis is BUYMar 11, 2019 ... ... shares at the public offering price, less underwriting discounts and commissions. All of the shares in the offering were sold by Apellis.Today, it's easy to get free stocks! In most cases, all you have to do is sign up for one of the investing apps on this list. Getting free stocks is simple - all you have to do is ...Feb 19, 2024 · Summary of all time highs, changes and price drops for Apellis Pharmaceuticals; Historical stock prices; Current Share Price: US$68.78: 52 Week High: US$94.75 ... Stock Information · News Releases · Events & Presentations · Corporate Governance · Financials & Filings · Investor FAQs · Inv...MSFT. Microsoft Corporation Common Stock. $371.19 +0.57 +0.15%. Apellis Pharmaceuticals, Inc. Common Stock (APLS) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading ... Get Apellis Pharmaceuticals Inc (APLS.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsNeedham Adjusts Price Target on Apellis Pharmaceuticals to $75 From $70, Maintains Buy Rating Jan. 24: MT Apellis Pharmaceuticals Insider Sold Shares Worth $872,961, According to a Recent SEC Filing ... Stock Apellis Pharmaceuticals, Inc. - …Apellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.Apellis Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.Feb 16, 2024 · The latest Apellis Pharmaceuticals stock prices, stock quotes, news, and APLS history to help you invest and trade smarter. ... According to the current price, Apellis Pharmaceuticals is 346.95% ... Apellis Pharmaceuticals Inc stock price (APLS) NASDAQ: APLS. ... Apellis Pharmaceuticals Inc stock performance at a glance. Check Apellis Pharmaceuticals Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.Apellis Pharmaceuticals Inc stock price (APLS) NASDAQ: APLS. ... Apellis Pharmaceuticals Inc stock performance at a glance. Check Apellis Pharmaceuticals Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.On average, Wall Street analysts predict. that Apellis Pharmaceuticals's share price could reach $72.47 by Jan 30, 2025. The average Apellis Pharmaceuticals stock price prediction forecasts a potential upside of 15.84% from …Apellis Pharmaceuticals, Inc. Price and Consensus. Apellis Pharmaceuticals, Inc. Price and Consensus. ... As China grapples with the fallout from a $7 trillion stock decline, officials are gearing ...How the News Affects Stock Prices. Stock prices tick up and down constantly due to fluctuations in supply and demand. If more people want to buy a stock, its market price will increase. If more ...Feb 16, 2024 · Despite its mid-2023 stock price collapse, Apellis stock has typically delivered strong value for investors. Its stock price is +385% over a 5-year period, and +122% over a 6-month period as it ... Apellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.With a net margin of -127.03%, the company may encounter challenges in effective cost control. Return on Equity (ROE): Apellis Pharmaceuticals's ROE is ... quarterly ratings for individual stocks.Apellis Pharmaceuticals Inc stock price (APLS) NASDAQ: APLS. ... Apellis Pharmaceuticals Inc stock performance at a glance. Check Apellis Pharmaceuticals Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.MT. Apellis Pharmaceuticals Insider Sold Shares Worth $469,905, According to a Recent SEC Filing. Jan. 24. MT. Needham Adjusts Price Target on Apellis Pharmaceuticals to $75 From $70, Maintains Buy Rating. Jan. 24. MT. Apellis Pharmaceuticals Insider Sold Shares Worth $872,961, According to a Recent SEC Filing. Jan. 24. Apellis Pharmaceuticals Inc stock price (APLS) NASDAQ: APLS. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Apellis Pharmaceuticals Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Apellis Pharmaceuticals Inc (APLS) stock has gained 4.16% while the S&P 500 is lower by -0.31% as of 11:15 AM on Tuesday, Jan 9. APLS has risen $2.85 from the previous closing price of $68.35 on volume of 1,003,015 shares. Over the past year the S&P 500 has risen 22.01% while APLS has risen 49.31%.Apellis Pharmaceuticals (APLS, $67.6) entered Uptrend as Momentum indicator ascends above 0 level on Feb 22, 2024 Tickeron - Stocks • 2 days ago This indicator may be signaling APLS's price has momentum to move higher, since its current price moved above its price 14 days ago.Raymond James raised their target price on shares of Apellis Pharmaceuticals from $67.00 to $106.00 and gave the stock a “strong-buy” rating in a report on Thursday, January 11th.Apellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.Related news Stock Upgrades: Apellis Pharmaceuticals Shows Rising Relative Strength. 1/29/2024 Apellis Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative ...View the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, historical charts, analyst ratings and financial information from WSJ.Complete Apellis Pharmaceuticals Inc. stock information by Barron's. View real-time APLS stock price and news, along with industry-best analysis. The stock's price-to-GF-Value ratio stands at 0.45, with a GuruFocus Value of $144.67, indicating that Apellis Pharmaceuticals Inc is currently categorized as a Possible Value Trap, Think Twice ...APLS stock forecast for 2023 – 2027. Last updated: September 22, 2023. APLS. Apellis Pharmaceuticals, Inc. 43.77 D 6.87% (3.23)Needham Adjusts Price Target on Apellis Pharmaceuticals to $75 From $70, Maintains Buy Rating Jan. 24: MT Apellis Pharmaceuticals Insider Sold Shares Worth $872,961, According to a Recent SEC Filing ... Stock Apellis Pharmaceuticals, Inc. - …Find the latest Apellis Pharmaceuticals, Inc. (APLS) stock quote, history, news and other vital information to help you with your stock trading and investing.View the basic APLS option chain and compare options of Apellis Pharmaceuticals, Inc. on Yahoo Finance.Jan 08, 2024 Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U.S. Net Product Revenues. Dec 14, 2023 8:30 AM EST. Click here for webcast. Investor Contact. Meredith Kaya. (617) 599-8178. [email protected]. Lissa Pavluk. (617) 977-6764.Apellis Pharmaceuticals Inc (APLS) stock is trading at $52.70 as of 10:56 AM on Thursday, Nov 30, an increase of $2.40, or 4.76% from the previous closing price of $50.30. The stock has traded between $50.52 and $54.96 so …Find the historical stock prices of Apellis Pharmaceuticals Inc. (APLS)Get the latest Apellis Pharmaceuticals Inc (1JK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Mar 28, 2022 ... ... Stock and Full Exercise of Option to Purchase Additional Shares. March 28 ... shares at the public offering price of $47.00 per share. The ...Find the historical stock prices of Apellis Pharmaceuticals Inc. (APLS)The firm's 50 day moving average price is $64.53 and its 200 day moving average price is $52.06. The company has a debt-to-equity ratio of 0.40, a quick ratio of 3.76 and a current ratio of 4.29. Apellis Pharmaceuticals, Inc. has a twelve month low of $19.83 and a twelve month high of $94.75.Apellis Pharmaceuticals, Inc. (APLS): $66.97 · Get Rating · Component Grades · APLS Stock Summary · APLS Valuation Summary · APLS's Quality F...Apellis Pharmaceuticals, Inc. (APLS Quick Quote APLS - Free Report) reported third-quarter 2023 loss of $1.17 per share, which was wider than the Zacks Consensus Estimate of a loss of 84 cents ...For instance, the price of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) stock is up an impressive 177% over the last five years. It's also good to see the share price up 19% over the last quarter.Jul 20, 2023 · The Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) share price has fared very poorly over the last month, falling by a substantial 55%.Instead of being rewarded, shareholders who have already held ... APLS support price is $59.34 and resistance is $64.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APLS stock will trade within this expected range on the day. View a ...Apellis Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. APLS updated stock price target summary. The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig...That disclosure suggested the safety issues may be unrelated to Syfovre itself, helping Apellis’ stock rebound. But at $43 apiece, shares are worth less than they were prior to Syfovre’s approval, and the company is still losing money. Apellis had a net loss of $122 million on drug sales of $95 million in the second quarter.Apellis Pharmaceuticals Inc Stock Price History. Apellis Pharmaceuticals Inc’s price is currently down 2.79% so far this month. During the month of November, Apellis Pharmaceuticals Inc’s stock price has reached a high of $51.74 and a low of $41.19. Over the last year, Apellis Pharmaceuticals Inc has hit prices as high as $94.75 …For instance, the price of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) stock is up an impressive 177% over the last five years. It's also good to see the share price up 19% over the last quarter.Since its approval, rare but serious side effects have marred an otherwise steady launch in the U.S., depressing Apellis’ stock price and, in October, triggering a major restructuring. Though Apellis has blamed faulty needles, not the treatment, for the safety problems, two weeks ago the FDA added a warning to Syfovre’s prescribing …Feb 16, 2024 · Apellis Pharmaceuticals Inc. (APLS) is a biotechnology company that develops and commercializes therapies for rare diseases. The stock price, performance, news, and analysis of APLS are available on MarketWatch. See the latest updates on APLS stock price, earnings, dividends, and ratings. Feb 16, 2024 · What was Apellis Pharmaceuticals Inc’s price range in the past 12 months? Apellis Pharmaceuticals Inc lowest stock price was $19.83 and its highest was $94.75 in the past 12 months. What is Apellis Pharmaceuticals Inc’s market cap? Apellis Pharmaceuticals Inc share price live 68.16, this page displays NASDAQ APLS stock exchange data. View the APLS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Apellis Pharmaceuticals Inc real time stock price chart below. You can find more details by …Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...APLS stock forecast Our latest prediction for Apellis Pharmaceuticals Inc's stock price was made on the Feb. 1, 2024 when the stock price was at 62.13$.. In the short term (2weeks), APLS's stock price should underperform the market by -2.09%.During that period the price should oscillate between -7.99% and +2.97%.. In the medium term …On Monday, Jefferies shifted its stance on Apellis Pharmaceuticals (NASDAQ:APLS), raising the stock from Hold to Buy and increasing the price target to $80 from the previous $68.... Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development ...On January 17, 2024, Jeffrey Eisele, Chief Development Officer of Apellis Pharmaceuticals Inc (NASDAQ:APLS), sold 5,207 shares of the company's stock, according to a recent SEC Filing. Get the ...Feb 16, 2024 · With Apellis Pharmaceuticals stock trading at $68.78 per share, the total value of Apellis Pharmaceuticals stock (market capitalization) is $8.15B. Apellis Pharmaceuticals stock was originally listed at a price of $14.03 in Nov 9, 2017. If you had invested in Apellis Pharmaceuticals stock at $14.03, your return over the last 6 years would have ... Oct 31, 2023 · Stock Upgrades: Apellis Pharmaceuticals Shows Rising Relative Strength Stocks With Rising Relative Price Strength: Apellis Pharmaceuticals Meta Stock, Nvidia, Toyota, Alphabet And 12 Others Enter ... 4 days ago · The Apellis Pharmaceuticals Inc. stock price gained 0.646% on the last trading day (Friday, 9th Feb 2024), rising from $68.12 to $68.56. During the last trading day the stock fluctuated 1.89% from a day low at $68.11 to a day high of $69.40. The price has risen in 6 of the last 10 days and is up by 7.06% over the past 2 weeks. APLS Stock Quote Price and Forecast | CNN View Apellis Pharmaceuticals, Inc. APLS stock quote prices, financial information, real-time forecasts, and company news from CNN. View... Apellis Pharmaceuticals, Inc. price-consensus-chart | Apellis Pharmaceuticals, Inc. Quote. Zacks Rank and Other Stocks to Consider. Apellis currently carries a Zacks Rank #2 (Buy).
The latest closing stock price for Apellis Pharmaceuticals as of February 05, 2024 is 68.16. The all-time high Apellis Pharmaceuticals stock closing price was 93.31 on June 13, 2023. The Apellis Pharmaceuticals 52-week high stock price is 94.75, which is 39% above the current share price. The Apellis Pharmaceuticals 52-week low stock price is ... . Eon kid
The Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) share price has fared very poorly over the last month, falling by a substantial 55%. Instead of being rewarded, shareholders who have already held ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past...APLS stock is rising on injection kit news. By William White, InvestorPlace Writer Aug 23, 2023, 8:28 am EST. Apellis Pharmaceuticals ( APLS) stock is rising on an injection kit update. The ...APLS: Apellis Pharmaceuticals Inc Stock Price Quote - NASDAQ GS - Bloomberg Subscribe S&P 500 4,975.51 –0.60% Nasdaq 15,630.78 –0.92% Crude Oil 78.27 –1.16% …Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...Apellis Pharmaceuticals, Inc. price-consensus-chart | Apellis Pharmaceuticals, Inc. Quote. Zacks Rank and Other Stocks to Consider. Apellis currently carries a Zacks Rank #2 (Buy).Needham Adjusts Price Target on Apellis Pharmaceuticals to $75 From $70, Maintains Buy Rating Jan. 24: MT Apellis Pharmaceuticals Insider Sold Shares Worth $872,961, According to a Recent SEC Filing ... Stock Apellis Pharmaceuticals, Inc. - …Nov 13, 2017 ... ... shares of common stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any. The shares ...Apellis Pharmaceuticals (APLS) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.Feb 16, 2024 · With Apellis Pharmaceuticals stock trading at $68.78 per share, the total value of Apellis Pharmaceuticals stock (market capitalization) is $8.15B. Apellis Pharmaceuticals stock was originally listed at a price of $14.03 in Nov 9, 2017. If you had invested in Apellis Pharmaceuticals stock at $14.03, your return over the last 6 years would have ... Get the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Apellis Pharma Stock Earnings. The value each APLS share was expected to gain vs. the value that each APLS share actually gained. Apellis Pharma ( APLS) reported Q3 2023 earnings per share (EPS) of -$1.17, missing estimates of -$0.99 by 17.35%. In the same quarter last year, Apellis Pharma 's earnings per share (EPS) was -$1.75..